Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Double-blind, Placebo-controlled, Parallel Group, Dose-titration Study to Determine the Efficacy and Safety of VA106483 in Male Subjects With Nocturia

NCT01038843 is registered in ClinicalTrials.gov with Vantia Ltd as lead sponsor.

NCT NCT01038843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01038843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Double-blind, Placebo-controlled, Parallel Group, Dose-titration Study to Determine the Efficacy and Safety of VA106483 in Male Subjects With Nocturia
Lead sponsor
Vantia Ltd
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2009
Completion date
August 31, 2010
Enrollment
152 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

nocturia